Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Behavior and symptom identification scale 32: sensitivity to change over time.

Jeanette M Jerrell1

  • 1Department of Neuropsychiatry and Behavioral Sciences, University of South Carolina School of Medicine, 3555 Harden St, Extension Suite 104A, Columbia, SC 29203, USA. jjerrell@gw.mp.sc.edu

The Journal of Behavioral Health Services & Research
|July 13, 2005
PubMed
Summary

The BASIS-32 scale effectively measures reliable changes in depression, anxiety, and psychosocial functioning for individuals with severe mental illness. However, it shows less sensitivity for detecting changes in impulsive behavior, psychosis, or overall scores.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology of Pediatric Hypertrophic Cardiomyopathy in a 10-Year Medicaid Cohort.

Pediatric cardiology·2020
Same author

Population-based treated prevalence, risk factors, and outcomes of bicuspid aortic valve in a pediatric Medicaid cohort.

Annals of pediatric cardiology·2018
Same author

Risk Factors for Heart Failure and Its Costs Among Children with Complex Congenital Heart Disease in a Medicaid Cohort.

Pediatric cardiology·2017
Same author

The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis.

Journal of clinical psychopharmacology·2017
Same author

Pharmacotherapy effectiveness for clinical subgroups among children and adolescents with early onset schizophrenia.

Human psychopharmacology·2017
Same author

Diagnostic clusters associated with an early onset schizophrenia diagnosis among children and adolescents.

Human psychopharmacology·2017

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Health Services Research

Background:

  • Assessing treatment efficacy requires outcome measures sensitive to clinical changes.
  • The Behavior and Symptom Identification Scale (BASIS-32) is used for evaluating mental health interventions.
  • Understanding the sensitivity of the BASIS-32 is crucial for accurate treatment assessment.

Purpose of the Study:

  • To evaluate the sensitivity of the BASIS-32 in detecting changes in symptoms and psychosocial functioning.
  • To assess the reliability and clinical significance of changes measured by the BASIS-32.
  • To determine the instrument's utility in a severe and persistent mental illness population.

Main Methods:

  • Utilized the Reliable Change Index (RCI) to analyze data.

Related Experiment Videos

  • Examined changes in symptom and psychosocial functioning ratings over time.
  • Analyzed data from 1188 individuals with severe and persistent mental illness over 3 years.

    • Main Results:

    • The BASIS-32 demonstrated sensitivity in detecting reliable and clinically significant changes in psychosocial functioning (relations with others, daily living/role functioning) and Depression/Anxiety.
    • Less reliable change was detected for impulsive/addictive behavior and psychosis subscales.
    • Statistically significant differences were observed for all measured areas, despite varying levels of reliable change detection.

    Conclusions:

    • The BASIS-32 is a sensitive measure for specific domains of psychosocial functioning and mood symptoms in severe mental illness.
    • Its utility in detecting reliable change for impulsive behavior, psychosis, and overall scores may be limited.
    • Further research may be needed to refine the interpretation of BASIS-32 scores for certain clinical presentations.